Glenmark Asks Fed. Circ. To Nix Patent In $16M Abbott Win
Glenmark Pharmaceuticals Ltd. on Friday slammed Abbott Laboratories' blood pressure drug Tarka as a "commercial disaster" that never should have received patent protection because of thousands of similar treatment combinations, urging...To view the full article, register now.
Already a subscriber? Click here to view full article